| Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
 | 2015 | Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study | Belinchón, Isabel; Vanaclocha, F.; De la Cueva-Dobao, P.; Coto-Segura, Pablo; Labandeira, J.; Herranz, P.; Taberner, R.; Juliá, B.; Cea-Calvo, L.; Puig, L. |  |
 | 2015 | Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry | Carretero, G.; Ferrandiz, C.; Dauden, E.; Vanaclocha Sebastián, F.; Gómez-García, F. J.; Herrera Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina-Gibert, M.; López Estebaranz, José Luis; Ferrán, M.; Torrado, R.; Carrascosa, J. M.; Carazo, C. | |
 | 2015 | Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry | Medina, C.; Carretero, G.; Ferrandiz, C.; Dauden, E.; Vanaclocha, F.; Gómez-García, F. J.; Herrera-Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina, M.; López Estebaranz, José Luis; Ferrán, M.; Carrascosa, J. M.; Torrado, R. | |
 | 2016 | Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis | Dávila-Seijo, Paula; Dauden, E.; Carretero, G.; Ferrandiz, C.; Vanaclocha, F.; Gómez-García, F. J.; Herrera-Ceballos, E.; De la Cueva-Dobao, P.; Belinchón, Isabel; Sánchez-Carazo, J. L.; Alsina, M.; López Estebaranz, José Luis; Ferrán, M.; Torrado, R.; Carrascosa, J. M. | |
.png){kind=logo}